BCL2L1 and small cell lung carcinoma: Out of 11 SCLC cell lines that were resistant to BCL-XL inhibitor (A1155463) alone in Fig. 1b, we selected the five most resistant cell lines to test against the combination of BCL-XL inhibitor and MCL-1 inhibitor.